Labcorp price target lowered to $213 from $234 at Barclays

Barclays lowered the firm’s price target on Labcorp (LH) to $213 from $234 and keeps an Equal Weight rating on the shares. The company’s Q1 print was marked by a headline beat and “mild” guidance raise that missed the high bar set by Quest Diagnostics (DGX) earlier this week, the analyst tells investors in a research note.